Why the study?
The study aimed to evaluate the relationship between preoperative American Society of Anesthesiology and Modified Charlson Comorbidty Index scores and postoperative survival in geriatric patients undergoing thoracic surgery.
Do preoperative ASA and Modified Charlson Comorbidity Index scores predict postoperative survival in geriatric patients undergoing thoracic surgery?
Do preoperative ASA and Modified Charlson Comorbidity Index scores predict postoperative survival in geriatric patients undergoing thoracic surgery?
The Modified Charlson Comorbidity Index and ASA scores are useful predictors of two-year mortality in geriatric patients undergoing elective thoracic surgery.
May aid preoperative risk stratification in geriatric thoracic surgery patients; leaves open prospective validation versus ASA score.
We aimed to evaluate the relationship between preoperative American Society of Anesthesiology and Modified Charlson Comorbidty Index scores and postoperative survival in geriatric patients who had undergone thoracic surgery. Methods: A total of 109 patients aged 65 years and above who had undergone thoracic surgery under elective conditions were included in this retrospective study. Results: Patients who died within the first postoperative two years had higher American Society of Anesthesiology III-IV scores (p=0.03), higher Modified Charlson Comorbidty Index scores (p=0.04), and lower hemoglobin and hematocrit values (p=0.02 and p=0.005, respectively). We found that Modified Charlson Comorbidty Index was significantly effective in predicting two-year mortality among geriatric patients (AUC = 0.648, 95% CI: 0.516-0.780, p=0.02). In the ROC analysis, the best predictive cut-off value for Modified Charlson Comorbidty Index was found to be 7 (sensitivity: 79.7%, and specificity: 44.4%).
No takes yet. Share an insight, caveat, or question.
Fatih Doğu Geyik (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: